Kenneth W Mahaffey MD
Adult Congenital Heart Disease
Associate Professor, Medicine, Duke University School of Medicine
Join to View Full Profile
300 Pasteur DrStanford, CA 94305
Phone+1 650-723-4000
Fax+1 650-498-5840
Dr. Mahaffey is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1993 - 1996
University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1989 - 1993
University of Washington School of MedicineClass of 1989
Certifications & Licensure
CA State Medical License 2014 - 2026
NC State Medical License 1996 - 2022
AZ State Medical License 1993 - 1994
American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 1 citationsSGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis.Brendon L Neuen, Robert A Fletcher, Stefan D Anker, Deepak L Bhatt, Javed Butler
JAMA. 2025-11-07 - 2 citationsEffects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis.Natalie Staplin, Alistair J Roddick, Brendon L Neuen, Stefan D Anker, Deepak L Bhatt
JAMA. 2025-11-07 - 4 citationsEffects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Tr...Peter Rossing, George Bakris, Vlado Perkovic, Richard Pratley, Katherine R Tuttle
Diabetes Care. 2025-11-01
Journal Articles
- Alirocumab and Cardiovascular Outcomes After Acute Coronary SyndromeVera A Bittner, Kenneth W Mahaffey, Deepak L Bhatt, Robert A Harrington, Gregory G Schwartz, Matthew T Roe, The New England Journal of Medicine
- Cardiovascular Outcomes After Lower Extremity Endovascular or Surgical RevascularizationKenneth Mahaffey, Manesh R Patel, W Schuyler Jones, William R Hiatt, Jeffrey S Berger, ScienceDirect
- Impact of Lesion Complexity on Peri-Procedural Adverse Events and the Benefit of Potent Intravenous Platelet Adenosine Diphosphate Receptor Inhibition After Percutaneo...Gregg W Stone, Matthew J Price, Philippe Genereux, C Michael Gibson, Deepak L Bhatt, Robert A Harrington, Kenneth W Mahaffey, European Heart Journal
- Join now to see all
Lectures
- Shark Tank Judge2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
- Effects of Canagliflozin on Heart Failure Outcomes With and Without Preserved Ejection Fraction in Type 2 Diabetes: Results From the CANVAS Program2019 ACC Scientific Session & Expo, New Orleans - 3/17/2019
- ROCKET-AF: Rivaroxaban Prevents Stroke as Effectively as Warfarin, With Lower Bleeding RiskAmerican Heart Association, Scientific Sessions 2010, Chicago, Illinois, USA
- Join now to see all
Authored Content
- 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical TrialsMarch 2017
Press Mentions
Idorsia to Collaborate with Two Leading Academic Medical Centers to Launch IMPACT-HTN - a US Initiative to Transform Care for Patients with Difficult-to-Control HypertensionSeptember 5th, 2025- Chinese Medicine Tongxinluo Yields ‘Surprising’ Benefits Post-STEMI: CTS-AMINovember 10th, 2022
- Chinese Herbal Medicine May Offer Benefits in STEMI: CTS-AMINovember 7th, 2022
- Join now to see all
Grant Support
- The LIMIting AAA with meTformin (LIMIT) TrialSTANFORD UNIVERSITY2020–2026
- 1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)STANFORD UNIVERSITY2019–2025
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
